Yossi Maimon

VP, Chief Financial Officer at PLX

Sold, on record
$4.1M
Dollars the filings state
Form 4 sales
8
Latest May 2, 2012
Form 144 notices
0
Proposed sales
Quarters with a sale
0 of the last 8
No sale in two years
Companies
1
Filed as an executive or holder

Companies

  • PLXProtalix BioTherapeutics, Inc.VP, Chief Financial Officer

Sales by reason

0
Routine
0
Plan not stated
0
No plan
8
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. May 2, 2012Unusual

    PLX

    Sold 100% of their holdings

    $898k125,964 shares at $7.13

    Filed May 4, 2012Form 4

  2. Oct 7, 2010Unusual

    PLX

    Sold 100% of their holdings

    $677k70,000 shares at $9.67

    Filed Oct 8, 2010Form 4

  3. Sep 7, 2010Unusual

    PLX

    Sold 100% of their holdings

    $565k70,000 shares at $8.07

    Filed Sep 8, 2010Form 4

  4. Oct 16, 2009Unusual

    PLX

    Sold 100% of their holdings

    $1.4M150,000 shares at $9.46

    Filed Oct 19, 2009Form 4

  5. Jul 7, 2009Unusual

    PLX

    Sold 100% of their holdings

    $255k50,000 shares at $5.11

    Filed Jul 8, 2009Form 4

  6. May 18, 2009Unusual

    PLX

    Sold 100% of their holdings

    $120k30,000 shares at $4.00

    Filed May 19, 2009Form 4

  7. Mar 13, 2009Unusual

    PLX

    Sold 100% of their holdings

    $109k48,590 shares at $2.24

    Filed Mar 13, 2009Form 4

  8. Feb 25, 2008Unusual

    PLX

    Sold 55.5% of their holdings

    $106k33,300 shares at $3.18

    Filed Feb 26, 2008Form 4

8 of 8

Every transaction

Every transaction on a Form 4 or Form 5 by Yossi Maimon
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Jan 19, 2023Jan 23, 2023Ayala Pharmaceuticals, Inc.CFO, Secretary and TreasurerReturned to the companyStock Option (right to buy)131,0800SEC
Jan 19, 2023Jan 23, 2023Ayala Pharmaceuticals, Inc.CFO, Secretary and TreasurerReturned to the company69,8720SEC
May 16, 2022May 16, 2022Ayala Pharmaceuticals, Inc.CFO, Secretary & TreasurerAwarded50,00069,872SEC
Jan 3, 2022Jan 5, 2022Ayala Pharmaceuticals, Inc.CFO, Secretary & TreasurerAwardedStock Option31,95031,950SEC
Jan 4, 2021Jan 6, 2021Ayala Pharmaceuticals, Inc.CFO, Secretary & TreasurerAwardedStock Option19,17019,170SEC
Jan 4, 2021Jan 6, 2021Ayala Pharmaceuticals, Inc.CFO, Secretary & TreasurerAwarded8,52019,872SEC
May 7, 2020May 11, 2020Ayala Pharmaceuticals, Inc.CFO, Secretary & TreasurerAwarded11,35211,352SEC
Sep 13, 2018Sep 14, 2018PLXVP, Chief Financial OfficerAwardedStock Options (Right to Buy)700,000700,000SEC
Dec 14, 2015Dec 15, 2015PLXVice President & CFOBought10,000$0.78$8k10,000SEC
Mar 23, 2015May 7, 2015PLXVP, Chief Financial OfficerAwardedStock Options (Right to Buy)250,000250,000SEC
Jul 16, 2012Jul 18, 2012PLXVice President & CFOAwarded185,000185,000SEC
May 2, 2012May 4, 2012PLXVP, Chief Financial OfficerSold125,964$7.13$898k0SEC
May 2, 2012May 4, 2012PLXVP, Chief Financial OfficerExercised or settledStock Options (Right to Buy)125,9640SEC
May 2, 2012May 4, 2012PLXVP, Chief Financial OfficerExercised options125,964$1.64$206k125,964SEC
Oct 7, 2010Oct 8, 2010PLXVP, Chief Financial OfficerSold70,000$9.67$677k0SEC
Oct 7, 2010Oct 8, 2010PLXVP, Chief Financial OfficerExercised or settledStock Options (Right to Buy)77,76975,964SEC
Oct 7, 2010Oct 8, 2010PLXVP, Chief Financial OfficerExercised options77,769$0.97$75k0SEC
Oct 7, 2010Oct 8, 2010PLXVP, Chief Financial OfficerWithheld for tax7,769$9.73$76k0SEC
Sep 7, 2010Sep 8, 2010PLXVP, Chief Financial OfficerSold70,000$8.07$565k0SEC
Sep 7, 2010Sep 8, 2010PLXVP, Chief Financial OfficerExercised or settledStock Options (Right to Buy)70,000153,733SEC
Sep 7, 2010Sep 8, 2010PLXVP, Chief Financial OfficerExercised options70,000$0.97$68k0SEC
Feb 25, 2010Feb 26, 2010PLXVP, Chief Financial OfficerAwardedStock Options (Right to Buy)130,000130,000SEC
Oct 16, 2009Oct 19, 2009PLXVP, Chief Financial OfficerSold150,000$9.46$1.4M0SEC
Oct 16, 2009Oct 19, 2009PLXVP, Chief Financial OfficerExercised or settledStock Options (Right to Buy)167,698223,733SEC
Oct 16, 2009Oct 19, 2009PLXVP, Chief Financial OfficerExercised options167,698$0.97$163k0SEC
Oct 16, 2009Oct 19, 2009PLXVP, Chief Financial OfficerWithheld for tax17,698$9.21$163k0SEC
Jul 7, 2009Jul 8, 2009PLXVP, Chief Financial OfficerSold50,000$5.11$255k0SEC
Jul 7, 2009Jul 8, 2009PLXVP, Chief Financial OfficerExercised or settledStock Options (Right to Buy)62,217391,431SEC
Jul 7, 2009Jul 8, 2009PLXVP, Chief Financial OfficerExercised options62,217$0.97$60k0SEC
Jul 7, 2009Jul 8, 2009PLXVP, Chief Financial OfficerWithheld for tax12,217$4.95$60k0SEC
May 18, 2009May 19, 2009PLXVP, Chief Financial OfficerSold30,000$4.00$120k0SEC
May 18, 2009May 19, 2009PLXVP, Chief Financial OfficerExercised or settledStock Options (Right to Buy)40,348453,648SEC
May 18, 2009May 19, 2009PLXVP, Chief Financial OfficerExercised options40,348$0.97$39k40,348SEC
May 18, 2009May 19, 2009PLXVP, Chief Financial OfficerWithheld for tax10,348$3.79$39k30,000SEC
Mar 13, 2009Mar 13, 2009PLXVP, Chief Financial OfficerSold48,590$2.24$109k0SEC
Mar 13, 2009Mar 13, 2009PLXVP, Chief Financial OfficerExercised or settledStock Options (Right to Buy)39,800493,996SEC
Mar 13, 2009Mar 13, 2009PLXVP, Chief Financial OfficerExercised options39,800$0.97$39k0SEC
Mar 13, 2009Mar 13, 2009PLXVP, Chief Financial OfficerWithheld for tax17,910$2.16$39k0SEC
Feb 25, 2009Feb 27, 2009PLXVP, Chief Financial OfficerAwardedStock Options (Right to Buy)50,00050,000SEC
Feb 25, 2008Feb 26, 2008PLXVP, Chief Financial OfficerSold33,300$3.18$106k26,700SEC
Feb 22, 2008Feb 26, 2008PLXVP, Chief Financial OfficerExercised or settledStock Options (Right to Buy)86,176533,796SEC
Feb 22, 2008Feb 26, 2008PLXVP, Chief Financial OfficerExercised options86,176$0.97$84k86,176SEC
Feb 22, 2008Feb 26, 2008PLXVP, Chief Financial OfficerWithheld for tax26,176$3.20$84k60,000SEC
Feb 7, 2008Feb 13, 2008PLXVP, Chief Financial OfficerAwardedStock Options (Right to Buy)175,000175,000SEC
Dec 31, 2006Jan 5, 2007PLXVP, Chief Financial OfficerAwardedStock Options (Right to Buy)619,972619,972SEC

Sales and notices (8)

Form 144 notices and Form 4 sales by Yossi Maimon
Source
May 2, 2012May 4, 2012PLXVP, Chief Financial OfficerForm 4 sale125,964$898k100.0%UnusualSEC
Oct 7, 2010Oct 8, 2010PLXVP, Chief Financial OfficerForm 4 sale70,000$677k100.0%UnusualSEC
Sep 7, 2010Sep 8, 2010PLXVP, Chief Financial OfficerForm 4 sale70,000$565k100.0%UnusualSEC
Oct 16, 2009Oct 19, 2009PLXVP, Chief Financial OfficerForm 4 sale150,000$1.4M100.0%UnusualSEC
Jul 7, 2009Jul 8, 2009PLXVP, Chief Financial OfficerForm 4 sale50,000$255k100.0%UnusualSEC
May 18, 2009May 19, 2009PLXVP, Chief Financial OfficerForm 4 sale30,000$120k100.0%UnusualSEC
Mar 13, 2009Mar 13, 2009PLXVP, Chief Financial OfficerForm 4 sale48,590$109k100.0%UnusualSEC
Feb 25, 2008Feb 26, 2008PLXVP, Chief Financial OfficerForm 4 sale33,300$106k55.5%UnusualSEC